Krieg Brian J, Taghavi Seyed Mohammad, Amidon Gordon L, Amidon Gregory E
College of Pharmacy, University of Michigan, Ann Arbor, Michigan, 48109.
Department of Chemical Engineering, Laval University, Quebec, Quebec City, G1V 0A6, Canada.
J Pharm Sci. 2015 Sep;104(9):2894-904. doi: 10.1002/jps.24460. Epub 2015 May 15.
Bicarbonate is the main buffer in the small intestine and it is well known that buffer properties such as pKa can affect the dissolution rate of ionizable drugs. However, bicarbonate buffer is complicated to work with experimentally. Finding a suitable substitute for bicarbonate buffer may provide a way to perform more physiologically relevant dissolution tests. The dissolution of weak acid and weak base drugs was conducted in bicarbonate and phosphate buffer using rotating disk dissolution methodology. Experimental results were compared with the predicted results using the film model approach of (Mooney K, Mintun M, Himmelstein K, Stella V. 1981. J Pharm Sci 70(1):22-32) based on equilibrium assumptions as well as a model accounting for the slow hydration reaction, CO2 + H2 O → H2 CO3 . Assuming carbonic acid is irreversible in the dehydration direction: CO2 + H2 O ← H2 CO3 , the transport analysis can accurately predict rotating disk dissolution of weak acid and weak base drugs in bicarbonate buffer. The predictions show that matching the dissolution of weak acid and weak base drugs in phosphate and bicarbonate buffer is possible. The phosphate buffer concentration necessary to match physiologically relevant bicarbonate buffer [e.g., 10.5 mM (HCO3 (-) ), pH = 6.5] is typically in the range of 1-25 mM and is very dependent upon drug solubility and pKa .
碳酸氢盐是小肠中的主要缓冲剂,众所周知,诸如pKa等缓冲特性会影响可离子化药物的溶解速率。然而,碳酸氢盐缓冲液在实验中使用起来很复杂。找到一种合适的碳酸氢盐缓冲液替代品可能为进行更具生理相关性的溶出度测试提供一种方法。采用旋转圆盘溶出度测定法,在碳酸氢盐和磷酸盐缓冲液中进行弱酸和弱碱药物的溶出实验。将实验结果与基于平衡假设以及考虑缓慢水合反应(CO2 + H2O → H2CO3)的模型的(Mooney K、Mintun M、Himmelstein K、Stella V. 1981. J Pharm Sci 70(1):22 - 32)薄膜模型方法预测的结果进行比较。假设碳酸在脱水方向上是不可逆的:CO2 + H2O ← H2CO3,传输分析可以准确预测弱酸和弱碱药物在碳酸氢盐缓冲液中的旋转圆盘溶出度。预测结果表明,使弱酸和弱碱药物在磷酸盐和碳酸氢盐缓冲液中的溶出度相匹配是可能的。与生理相关的碳酸氢盐缓冲液[例如,10.5 mM(HCO3(-)),pH = 6.5]相匹配所需的磷酸盐缓冲液浓度通常在1 - 25 mM范围内,并且非常依赖于药物溶解度和pKa。